Page last updated: 2024-10-25

ciglitazone and Proteinuria

ciglitazone has been researched along with Proteinuria in 2 studies

ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.

Proteinuria: The presence of proteins in the urine, an indicator of KIDNEY DISEASES.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tyagi, N1
Moshal, KS1
Lominadze, D1
Ovechkin, AV1
Tyagi, SC1
Yousefipour, Z1
Hercule, H1
Truong, L1
Oyekan, A1
Newaz, M1

Other Studies

2 other studies available for ciglitazone and Proteinuria

ArticleYear
Homocysteine-dependent cardiac remodeling and endothelial-myocyte coupling in a 2 kidney, 1 clip Goldblatt hypertension mouse model.
    Canadian journal of physiology and pharmacology, 2005, Volume: 83, Issue:7

    Topics: Acetylcholine; Animals; Blotting, Western; Collagen; Endothelin-1; Endothelium, Vascular; Fibrosis;

2005
Ciglitazone, a peroxisome proliferator-activated receptor gamma inducer, ameliorates renal preglomerular production and activity of angiotensin II and thromboxane A2 in glycerol-induced acute renal failure.
    The Journal of pharmacology and experimental therapeutics, 2007, Volume: 322, Issue:2

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acute Kidney Injury; Angiotensin

2007